Phio Pharmaceuticals Corp (PHIO)
1.08
+0.00%
Phio Pharmaceuticals Corp (PHIO) is currently trading at $1.08. This represents a gain of 0% from the previous session. With a market capitalization of $0.01B, PHIO is a key component of the Health Care sector. Investors looking to trade PHIO should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade PHIO commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Phio Pharmaceuticals Corp (PHIO) shows a bullish trend. Analysts are watching the 1.09 level closely.
Fundamentals
Mkt Cap0.01B
P/E Ratio0.0000
Volume102,715
60-Day Technical Chart
Advanced Charting
Need more indicators for PHIO? Use the world's #1 platform.
Open PHIO on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $1
| Metric |
PHIO +0.00% |
ABTC +7.84% |
HUMA +4.91% |
NFE +0.87% |
|---|---|---|---|---|
| Price | $1.08 | $1.10 | $1.18 | $1.16 |
| Mkt Cap | $0.01B | $1.01B | $0.23B | $0.33B |
| - | View → | View → | View → |
Latest Headlines
Top PH-762 skin cancer dose triggers 85% tumor response in Phio trial
Stock Titan • Feb 10, 2026
$PHIO stock is down 23% today. Here's what we see in our data.
Quiver Quantitative • Feb 18, 2026
Phio Pharmaceuticals Stock Falls 5% Amid Financing And Clinical Updates
Nasdaq • Nov 3, 2025
Phio Pharmaceuticals stock soars after strong cancer treatment results
Investing.com • Feb 10, 2026
Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
Yahoo Finance • Nov 3, 2025
● Gemini Agentic AI Analyst Insight for PHIO
Market Education
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
- 10 rules of money - Follow this and you are set for life Jul 16, 2023
- How to Protect and Grow Wealth as Interest Rates Fall Sep 27, 2025
External Research